Tissue vs liquid biopsy for molecular testing in lung cancer

Speaker: Fabrice Barlesi

Fabrice Barlesi explains the problems oncologists face with tissue biopsy for molecular testing in lung cancer and promise of liquid biopsy, in particular plasma and novel urinary techniques.

Discussion Points

  • Problems in tissue biopsy for molecular testing in lung cancer patients
  • Utility of circulation-free tumour-derived DNA in plasma and urinary circulating tumour DNA for EGFR mutation testing
  • How reliable is EGFR mutation testing in ultrasound guided supraclavicular lymph node fine needle aspirates

Abstracts Discussed